Microwave assisted solvent-free mannich bases: synthesis, characterization and effects of these compounds on HCA I and HCA II isozymes

Bülent Büyükkıdan, Nurgün Büyükkıdan, Metin Bülbül, Melek Yılmaz, Evren Derrun Arslanbay, Ekrem Tunca


Mannich bases (2ad) of aromatic amines were synthesized by using a conventional microwave technique under solvent-free conditions and characterized by IR and NMR (1H and 13C) and elemental analysis. The inhibitory effects of the synthesized Mannich bases were examined in vitro by using hydratase and esterase assays on carbonic anhydrase I and II isozymes (hCA, EC purified from human erythrocyte cells. Acetazolamide was used as the control compound. The values of IC50, the half-maximum inhibitory concentration, were found for hydratase and esterase activities. Only two compounds (2b and 2d) exhibited poor hCA I and hCA II inhibition effects on esterase activity. In contrast, compounds 2a and 2c could be used as carbonic anhydrase activators as a result of the increased esterase activity of hCA I and hCA II isozymes.


Activator, carbonic anhydrase, glaucoma, isozyme

Full Text:



J. Lehtonen, B. Shen, M. Vihinen, A. Casini, A. Scozzaf-ava, C. T. Supuran, A. K. Parkkila, J. Saarnio, A. J. Kive-lä, A. Waheed, W. S. Sly, S. Parkkila, Characterization of CA XIII, a novel member of the carbonic anhydrase iso-zyme family, J. Biol. Chem. 279, 2719–2727 (2004). DOI: 10.1074/jbc.M308984200

S. Beydemir, I. Gulcin, Effects of Melatonin on Carbonic Anhydrase from Human Erythrocytes In Vitro and from Rat Erythrocytes In Vivo, J. Enzym. Inhib. Med. Ch. 19, 193–197 (2004).

DOI: https://doi.org/10.1080/14756360310001656736.

D. Neri, C. T. Supuran, Interfering with pH regulation in tumours as a therapeutic strategy, Nat. Rev. Drug Discov. 10, 767–777 (2011).

DOI: https://doi.org/10.1038/nrd3554.

C. T. Supuran, A. Scozzafava, A. Cassini, Carbonic an-hydrase inhibitors, Med. Res. Rev. 23, 146–189 (2003).

DOI: https://doi.org/10.1002/med.10025

A. Scozzafava, T. Owa, A. Mastrolorenzo, C. T. Supuran, Anticancer and Antiviral Sulfonamides, Curr. Med. Chem. 10, 925–953 (2003).

DOI: https://doi.org/10.2174/0929867033457647.

A. Casini, J. Antel, F. Abbate, A. Scozzafava, S. David, H. Waldeck, S. Schafer, C. T. Supuran, Carbonic anhy-drase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV, Bioorg. Med. Chem. Lett. 13, 841–845 (2003).

DOI: https://doi.org/10.1016/S0960-894X(03)00029-5.

M. Guney, A. Coskun, F. Topal, A. Dastan, I. Gulcin, C. T. Supuran, Oxidation of cyanobenzocycloheptatrienes: Synthesis, photooxygenation reaction and carbonic anhy-drase isoenzymes inhibition properties of some new ben-zotropone derivatives, Bioorgan. Med. Chem. 22, 3537–3543 (2014).

DOI: https://doi.org/10.1016/j.bmc.2014.04.007.

W. S. Sly, P. Y. Hu, Human carbonic anhydrases and carbonic anhydrase deficiencies, Annu. Rev. Biochem. 64, 375–401 (1995).

DOI: https://doi.org/10.1146/annurev.bi.64.070195.002111.

J. C. Montgomery, P. J. Venta, R. L. Eddy, Y. S. Fuku-shima, T. B. Shows, R. E. Tashian, Characterization of the human gene for a newly discovered carbonic anhydrase, CA VII, and its localization to chromosome 16, Ge-nomics. 11, 835–848 (1991).

DOI: https://doi.org/10.1016/0888-7543(91)90006-Z.

A. Di Fiore, A. Scozzafava, J. Y. Winum, J. L. Montero, C. Pedone, C. T. Supuran, Carbonic anhydrase inhibitors: Binding of an antiglaucoma glycosyl-sulfanilamide deriv-ative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties, Bioorg. Med. Chem. Lett. 17, 1726–1731 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.12.099.

A. Innocenti, D. Vullo, J. Pastorek, A. Scozzafava, S. Pastorekova, I. Nishimori, C. T. Supuran, Carbonic an-hydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions, Bioorg. Med. Chem. Lett. 17, 1532–1537 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.12.113.

J. Y. Winum, A. Thiry, K. E. Cheikh, J. M. Dogné, J. L. Montero, D. Vullo, A. Scozzafava, B. Masereel, C. T. Supuran, Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfona-mides incorporating fructopyranose–thioureido tails, Bioorg. Med. Chem. Lett. 17, 2685–2691 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2007.03.008.

C. Yenikaya, M. Sarı, M. Bülbül, H. İlkimen, H. Celik H. O. Büyükgüngör, Synthesis, characterization and an-tiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn (II) complex, Bioorgan. Med. Chem. 18, 930–938 (2010).

DOI: https://doi.org/10.1016/j.bmc.2009.11.031.

B. L. Wilkinson, L. F. Bornaghi, T. A. Houston, A. In-nocenti, D. Vullo, C. T. Supuran, S. A. Poulsen, Inhibi-tion of membrane-associated carbonic anhydrase iso-zymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides, Bioorg. Med. Chem. Lett. 17, 987–992 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.11.046.

M. A. Santos, S. Marques, D. Vullo, A. Innocenti, A. Scozzafava, C. T. Supuran, Carbonic anhydrase inhibi-tors: Inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties Bioorg. Med. Chem. Lett. 17, 1538–1543 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.12.107.

C. T. Supuran, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat. Rev. Drug Discov. 7, 168–181 (2008). DOI: 10.1038/nrd2467.

C. Temperini, A. Scozzafava, D. Vullo, C. T. Supuran, Carbonic Anhydrase Activators. Activation of Isoforms I, II, IV, VA, VII, and XIV with L- and D-Phenylalanine and Crystallographic Analysis of Their Adducts with Iso-zyme II: Stereospecific Recognition within the Active Site of an Enzyme and Its Consequences for the Drug Design, J. Med. Chem. 49, 3019–3027 (2006).

DOI: https://doi.org/10.1021/jm0603320.

C. Temperini, A. Innocenti, A. Scozzafava, A. Mastrolo-renzo, C. T. Supuran, Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV, Bioorg. Med. Chem. Lett. 17, 628–635 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.11.027.

S. Parkkila, D. Vullo, L. Puccetti, A. K. Parkkila, A. Scozzafava, C. T. Supuran, Carbonic anhydrase activa-tors: activation of isozyme XIII with amino acids and amines, Bioorg. Med. Chem. Lett. 16, 3955–3959 (2006).

DOI: https://doi.org/10.1016/j.bmcl.2006.05.023.

D. Vullo, I. Nishimori, A. Innocenti, A. Scozzafava, C. T. Supuran, Carbonic anhydrase activators: An activation study of the human mitochondrial isoforms VA and VB with amino acids and amines, Bioorg. Med. Chem. Lett. 17, 1336–1340 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2006.11.075.

D. Vullo, A. Innocenti, I. Nishimori, A. Scozzafava, K. Kaila, C. T. Supuran, Carbonic anhydrase activators: acti-vation of the human isoforms VII (cytosolic) and XIV (transmembrane) with amino acids and amines, Bioorg. Med. Chem. Lett. 17, 4107–4112 (2007).

DOI: https://doi.org/10.1016/j.bmcl.2007.05.052.

I. Nishimori, S. Onishi, D. Vullo, A. Innocenti, A. Scoz-zafava, C. T. Supuran, Carbonic anhydrase activators: the first activation study of the human secretory isoform VI with amino acids and amines, Bioorgan. Med. Chem. 15, 5351–5357 (2007).

DOI: https://doi.org/10.1016/j.bmc.2007.03.004.

M. S. Singh, S. Chowdhury, Recent developments in solvent-free multicomponent reactions: a perfect synergy for eco-compatible organic synthesis, RSC. Adv. 2, 4547–4592 (2012). DOI: 10.1039/C2RA01056A.

A. Kumar, S. A. Sharma, A grinding-induced catalyst-and solvent-free synthesis of highly functionalized 1,4-dihydropyridines via a domino multicomponent reaction, Green Chem. 13, 2017–2020 (2011).

DOI: 10.1039/C1GC15223H.

N. Büyükkıdan, S. Özer, Synthesis and characterization of Ni (II) and Cu (II) complexes derived from novel phe-nolic Mannich bases, Turk. J. Chem. 37, 101–110 (2013). DOI:10.3906/kim-1203-67.

M. Ashok, B. S. Holla, B. Poojary, Convenient one pot synthesis and antimicrobial evaluation of some new Man-nich bases carrying 4-methylthiobenzyl moiety, Eur. J. Med. Chem. 42, 1095–1101 (2007).

DOI: https://doi.org/10.1016/j.ejmech.2007.01.015.

B. S. Holla, K. N. Poojary, R. B. Sooryanarayana, M. K. Shivananda, New bis aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents, Eur. J. Med. Chem. 37, 511–517 (2002).

DOI: https://doi.org/10.1016/S0223-5234(02)01358-2.

M. Amir, K. Shikha, Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid de-rivatives, Eur. J. Med. Chem. 39, 535–545 (2004).

DOI: https://doi.org/10.1016/j.ejmech.2004.02.008.

K. Walczak, A. Gondela, J. Suwiński, Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles, Eur. J. Med. Chem. 39, 849–853 (2004).

DOI: https://doi.org/10.1016/j.ejmech.2004.06.014.

N. Büyükkidan, B. Büyükkidan, M. Bülbül, R. Kasi-moğullari, M. Serdar, S. Mert, Synthesis and characteri-sation of novel Co(II) complexes of pyrazole carboxylate derivated sulfonamide as carbonic anhydrase inhibitors, J. Pharm. Pharmacol. 65, 363–369 (2013).

DOI: https://doi.org/10.1111/j.2042-7158.2012.01609.x.

N. Büyükkidan, B. Büyükkidan, M. Bülbül, R. Kasi-moğullari, S. Mert, Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfona-mide on human erythrocyte carbonic anhydrase isozymes I and II, J. Enzym. Inhib. Med. Ch. 32, 208–213 (2017).

DOI: https://doi.org/10.1080/14756366.2016.1247056.

E. Tunca, M. Bülbül, H. İlkimen, R. Saygılı Canlıdinç, C. Yenikaya, Investigation of the effects of the proton trans-fer salts of 2-aminopyridine derivatives with 5-sulfosalicylic acid and their Cu(II) complexes on cancer-related carbonic anhydrases CA IX and CA XII, Chem. Pap. 74, 2365–2374 (2020).

DOI: https://doi.org/10.1007/s11696-020-01078-5.

E. E. Rickli, S. A. S. Ghazanfar, B. H. Gibbons, J. T. Edsall, Carbonic anhydrases from human erythrocytes preparation and properties of two enzymes, J. Biol. Chem. 239, 1065–1078 (1964).

DOI: https://doi.org/10.1016/S0021-9258(18)91392-X.

M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248–254 (1976).

DOI: https://doi.org/10.1016/0003-2697(76)90527-3.

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature 227, 680–685 (1970).

DOI: https://doi.org/10.1038/227680a0.

Y. Kitazawa, I. Azuma, K. Iwata, S. Tsukahara, Y. Shiose, M. Araie, S. Shirato, K. Mizogami, H. Mishima, R. Futa, S. Komemushi, Dorzolamide, a topical carbonic anhy-drase inhibitor: a two-week dose-response study in pa-tients with glaucoma or ocular hypertension, J. Glaucoma 3, 275–279 (1994).


K. M. Wilbur, N. G. Anderson, Electrometric and colori-metric determination of carbonic anhydrase, J. Biol. Chem. 176, 147–154 (1948).

DOI: https://doi.org/10.1016/S0021-9258(18)51011-5.

J. A. Verpoorte, S. Mehta, J. T. Edsall, Esterase activities of human carbonic anhydrases B and C, J. Biol. Chem. 242, 4221–4229 (1967).

DOI: https://doi.org/10.1016/S0021-9258(18)95800-X.

A. Innocenti, A. Scozzafava, S. Parkkila, L. Puccetti, G. De Simone, Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian car-bonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates, Bioorg. Med. Chem Lett. 18, 2267–2271 (2008).

DOI: https://doi.org/10.1016/j.bmcl.2008.03.012.

V. Alterio, A. Di Fiore, K. D.’Ambrosio, C. T. Supuran, G. De Simone, Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs target-ing 15 different isoforms?, Chem. Rev. 112, 4421–4468 (2012).

DOI: https://doi.org/10.1021/cr200176r.

DOI: http://dx.doi.org/10.20450/mjcce.2021.1968


  • There are currently no refbacks.

Copyright (c) 2021 Bülent Büyükkıdan, Nurgün Büyükkıdan, Metin Bülbül, Melek Yılmaz, Evren Derrun Arslanbay, Ekrem Tunca

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.